Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
Abstract The assessment in real‐life conditions of the safety and efficacy of new antimalarial drugs is of greatest interest. This study aimed to monitor and evaluate both clinical and biological safety of pyronaridine‐artesunate (PA) in real‐life conditions in Burkina Faso's health system. Thi...
Main Authors: | Toussaint Rouamba, Paul Sondo, Isidore W. Yerbanga, Adelaide Compaore, Maminata Traore‐Coulibaly, Franck S. Hien, Nassirou A. Diande, Innocent Valea, Marc Christian Tahita, Rita Baiden, Fred Binka, Halidou Tinto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-08-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.987 |
Similar Items
-
Efficacy and safety of pyronaridine-artesunate (Pyramax®) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia
by: Hussein Mohammed, et al.
Published: (2022-12-01) -
Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
by: Johanna M. Roth, et al.
Published: (2018-06-01) -
Therapeutic efficacy of pyronaridine-artesunate (Pyramax®) against uncomplicated Plasmodium falciparum infection at Hamusit Health Centre, Northwest Ethiopia
by: Mihreteab Alebachew, et al.
Published: (2023-06-01) -
Efficacy and safety of pyronaridine–artesunate versus artemether–lumefantrine in the treatment of acute uncomplicated malaria in children in South-West Nigeria: an open-labelled randomized controlled trial
by: Catherine O. Falade, et al.
Published: (2023-05-01) -
Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso
by: Yves Daniel Compaoré, et al.
Published: (2021-01-01)